Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has issued an update.
Jubilant Pharmova’s step-down subsidiary, Jubilant Generics Limited, has invested CAD 30,000 (about INR 0.20 crore) in Jubilant Pharmaceuticals Inc., a newly incorporated Canadian entity that will operate in the pharmaceuticals industry and is yet to commence business operations. With this initial cash investment, Jubilant Pharmaceuticals Inc. becomes a step-down wholly owned subsidiary, providing the group a direct platform to build a branded generics business in Canada, strengthen its presence in the Canadian market, and support future revenue growth without requiring additional regulatory approvals for the acquisition.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceuticals industry through various subsidiaries, with a focus on generics and related pharmaceutical products and services across global markets. Its step-down subsidiary Jubilant Generics Limited and newly incorporated Jubilant Pharmaceuticals Inc. in Canada are part of its strategy to expand branded generics offerings internationally, particularly in regulated markets such as North America.
Average Trading Volume: 7,027
Technical Sentiment Signal: Buy
Current Market Cap: 171.1B INR
See more insights into JUBLPHARMA stock on TipRanks’ Stock Analysis page.